Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences Ltd has informed BSE that its Board of Directors will meet on Monday, 2nd February 2026. The main agenda is to approve and take on record the un-audited financial results for the quarter and nine months ended 31st December 2025 (Q3 FY26). The notice also includes a standard provision for any other matter with the Board's permission. The intimation is filed under Regulation 29 of SEBI LODR Regulations, 2015. No financial figures or business details are disclosed in this filing — it is purely a pre-results procedural announcement.
This is a routine compliance filing ahead of the company's Q3 FY26 earnings announcement. Investors should watch for the actual results on or after 2nd February 2026; no immediate impact on share price is expected from this notice alone.